课题基金 / 基金详情

Covid-19 - SARS-CoV-2 Multi Surface Disinfection Spray System

Covid-19 - SARS-CoV-2 Multi Surface Disinfection Spray System
Covid-19 - SARS-CoV-2 多表面消毒喷雾系统
批准号:
77807
负责人:
金额:
$22.55万
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
关键词:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
COVID-19给医疗系统带来了独特的挑战。有效的感染控制包括清洁(去除有机物、灰尘等)和消毒(减少微生物数量到无害的水平)有第二波的威胁;据英国广播公司2020年7月17日报道,公共卫生专家警告说,在医疗环境中提供有效的工具来对抗这种疾病是势在必行的。VIRUSEND(tm)在所有领域都有效用,并且将是其类型中唯一被证明对COVID有效的产品-19沿着着广泛的细菌和其他病毒。这将有助于通过最大限度地减少病毒传播来保护健康,使雇主能够履行其法律的义务,尽可能减少风险,并提供一个环保和可持续的感染控制解决方案。
英文摘要
COVID-19 presents unique challenges to healthcare systems. Effective infection control involves cleaning (remove organic matter, dust etc.) and disinfection (reduce number of micro-organisms to a level where they are not harmful)With the threat of a second wave; as reported on the BBC 17-07-2020, being warned of by public health experts, providing effective tools to fight this disease in medical setting is imperative.VIRUSEND(tm) has utility across all sectors and will be the only product of its type that has proven efficacy against COVID-19 along with a broad range of bacteria and other viruses. This will help protect health by minimising the spread of the virus, enable employers to meet their legal obligations to reduce risk as far as practically possible and provide an environmentally friendly and sustainable solution to infection control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位: